Cargando…
After Experimental Trypanosoma cruzi Infection, Dying Hepatic CD3(+)TCRαβ(+)B220(+) T Lymphocytes Are Rescued from Death by Peripheral T Cells and Become Activated
The unusual phenotype of CD3(+) T lymphocyte expressing B220, a marker originally attributed to B lymphocytes, was first observed in the liver of Fas/Fas-L-deficient mice as a marker of apoptotic T lymphocytes. However, other CD3(+)B220(+) T lymphocyte populations were later described in the periphe...
Autores principales: | Vacani-Martins, Natalia, Meuser-Batista, Marcelo, Moreira, Otacilio C., Cascabulho, Cynthia Machado, Gois Beghini, Daniela, Horita, Samuel Iwao, Batista, Marcos Meuser, Freitas, Fernando Cleber, Guimarães, Juliana Rodrigues, Henriques-Pons, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559066/ https://www.ncbi.nlm.nih.gov/pubmed/32878101 http://dx.doi.org/10.3390/pathogens9090717 |
Ejemplares similares
-
In the presence of Trypanosoma cruzi antigens, activated peripheral T lymphocytes retained in the liver induce a proinflammatory phenotypic and functional shift in intrahepatic T lymphocyte
por: Meuser‐Batista, Marcelo, et al.
Publicado: (2020) -
The Liver and the Hepatic Immune Response in Trypanosoma cruzi Infection, a Historical and Updated View
por: Vacani-Martins, Natalia, et al.
Publicado: (2021) -
In vivo imaging of mice infected with bioluminescent Trypanosoma cruzi unveils novel sites of infection
por: Henriques, Cristina, et al.
Publicado: (2014) -
Induced Pluripotent Stem Cells: Hope in the Treatment of Diseases, including Muscular Dystrophies
por: Gois Beghini, Daniela, et al.
Publicado: (2020) -
Mesenchymal Stem Cells in the Treatment of COVID-19, a Promising Future
por: Beghini, Daniela Gois, et al.
Publicado: (2021)